1. Home
  2. NKTX vs BTMD Comparison

NKTX vs BTMD Comparison

Compare NKTX & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • BTMD
  • Stock Information
  • Founded
  • NKTX 2015
  • BTMD 2012
  • Country
  • NKTX United States
  • BTMD United States
  • Employees
  • NKTX N/A
  • BTMD N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • BTMD Medicinal Chemicals and Botanical Products
  • Sector
  • NKTX Health Care
  • BTMD Health Care
  • Exchange
  • NKTX Nasdaq
  • BTMD Nasdaq
  • Market Cap
  • NKTX 123.5M
  • BTMD 129.1M
  • IPO Year
  • NKTX 2020
  • BTMD N/A
  • Fundamental
  • Price
  • NKTX $1.77
  • BTMD $3.96
  • Analyst Decision
  • NKTX Strong Buy
  • BTMD Strong Buy
  • Analyst Count
  • NKTX 6
  • BTMD 1
  • Target Price
  • NKTX $14.40
  • BTMD $8.00
  • AVG Volume (30 Days)
  • NKTX 422.2K
  • BTMD 125.8K
  • Earning Date
  • NKTX 08-12-2025
  • BTMD 08-07-2025
  • Dividend Yield
  • NKTX N/A
  • BTMD N/A
  • EPS Growth
  • NKTX N/A
  • BTMD 201.68
  • EPS
  • NKTX N/A
  • BTMD 0.60
  • Revenue
  • NKTX N/A
  • BTMD $199,379,000.00
  • Revenue This Year
  • NKTX N/A
  • BTMD $5.87
  • Revenue Next Year
  • NKTX N/A
  • BTMD $8.59
  • P/E Ratio
  • NKTX N/A
  • BTMD $6.62
  • Revenue Growth
  • NKTX N/A
  • BTMD 6.44
  • 52 Week Low
  • NKTX $1.31
  • BTMD $3.04
  • 52 Week High
  • NKTX $8.23
  • BTMD $8.44
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 46.34
  • BTMD 54.48
  • Support Level
  • NKTX $1.76
  • BTMD $3.85
  • Resistance Level
  • NKTX $2.08
  • BTMD $4.05
  • Average True Range (ATR)
  • NKTX 0.11
  • BTMD 0.19
  • MACD
  • NKTX -0.00
  • BTMD 0.01
  • Stochastic Oscillator
  • NKTX 25.00
  • BTMD 65.55

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.

Share on Social Networks: